Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) EBT Margin: 2018-2025

Historic EBT Margin for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to -78.41%.

  • Arcturus Therapeutics Holdings' EBT Margin fell 6132.00% to -78.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -68.35%, marking a year-over-year decrease of 2946.00%. This contributed to the annual value of -53.14% for FY2024, which is 3642.00% down from last year.
  • Arcturus Therapeutics Holdings' EBT Margin amounted to -78.41% in Q3 2025, which was down 141.83% from -32.42% recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' EBT Margin ranged from a high of 74.02% in Q4 2022 and a low of -2,711.14% during Q1 2021.
  • Moreover, its 3-year median value for EBT Margin was -37.09% (2023), whereas its average is -83.08%.
  • In the last 5 years, Arcturus Therapeutics Holdings' EBT Margin crashed by 235,355bps in 2021 and then skyrocketed by 260,507bps in 2022.
  • Arcturus Therapeutics Holdings' EBT Margin (Quarterly) stood at -649.72% in 2021, then surged by 72,374bps to 74.02% in 2022, then crashed by 11,111bps to -37.09% in 2023, then plummeted by 9,472bps to -131.81% in 2024, then plummeted by 6,132bps to -78.41% in 2025.
  • Its last three reported values are -78.41% in Q3 2025, -32.42% for Q2 2025, and -47.91% during Q1 2025.